FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896109871> ?p ?o ?g. }

• W2896109871 endingPage "117" @default.
• W2896109871 startingPage "107" @default.
• W2896109871 abstract "<b><i>Background/Aims:</i></b> Epithelial ovarian cancer (EOC) is the sixth most commonly diagnosed cancer among women. Results with available therapies are far from being satisfactory and, therefore, current research is focusing on new anticancer drugs to improve the clinical response of these patients. Nintedanib is an oral multiple tyrosine kinases inhibitor, which targets angiogenesis. Considering the current scenario, the aim of this systematic review is to highlight the prevailing knowledge about pharmacokinetics, pharmacodynamics, clinical efficacy, and safety of Nintedanib for the treatment of advanced EOC. <b><i>Methods:</i></b> We performed a systematic review of the literature, screening all available articles about the treatment of advanced EOC with Nintedanib, including phase I, II, and III trials. <b><i>Results:</i></b> Although in early phase clinical trials, Nintedanib has demonstrated anticancer activity and tolerability as monotherapy or in combination with carboplatin and paclitaxel. In the phase III trial AGO-OVAR 12, it obtained a modest improvement in progression-free survival (PFS) as first-line combination therapy for patients with advanced EOC. Interestingly, a PFS increase was observed in patients with non-high progression risk or low tumor burden. <b><i>Conclusion:</i></b> Despite the promising results, further studies are needed to evaluate Nintedanib efficacy in women affected by EOC." @default.
• W2896109871 created "2018-10-26" @default.
• W2896109871 creator A5033337879 @default.
• W2896109871 creator A5046855515 @default.
• W2896109871 creator A5059475139 @default.
• W2896109871 creator A5060735908 @default.
• W2896109871 creator A5068554505 @default.
• W2896109871 date "2018-10-10" @default.
• W2896109871 modified "2023-10-18" @default.
• W2896109871 title "Nintedanib for Advanced Epithelial Ovarian Cancer: A Change of Perspective? Summary of Evidence from a Systematic Review" @default.
• W2896109871 cites W1965498557 @default.
• W2896109871 cites W1967442764 @default.
• W2896109871 cites W1974122093 @default.
• W2896109871 cites W1988509493 @default.
• W2896109871 cites W1991853425 @default.
• W2896109871 cites W1998258610 @default.
• W2896109871 cites W2015252006 @default.
• W2896109871 cites W2020259214 @default.
• W2896109871 cites W2029115213 @default.
• W2896109871 cites W2033957860 @default.
• W2896109871 cites W2041766813 @default.
• W2896109871 cites W2044212847 @default.
• W2896109871 cites W2077804275 @default.
• W2896109871 cites W2089756110 @default.
• W2896109871 cites W2102306754 @default.
• W2896109871 cites W2118256381 @default.
• W2896109871 cites W2124587459 @default.
• W2896109871 cites W2128178813 @default.
• W2896109871 cites W2133537644 @default.
• W2896109871 cites W2134657639 @default.
• W2896109871 cites W2140856191 @default.
• W2896109871 cites W2146878122 @default.
• W2896109871 cites W2148326226 @default.
• W2896109871 cites W2150450484 @default.
• W2896109871 cites W2158366593 @default.
• W2896109871 cites W2171658624 @default.
• W2896109871 cites W2192853737 @default.
• W2896109871 cites W2302106606 @default.
• W2896109871 cites W2329601337 @default.
• W2896109871 cites W2336533464 @default.
• W2896109871 cites W2397553904 @default.
• W2896109871 cites W2523518762 @default.
• W2896109871 cites W2544674952 @default.
• W2896109871 cites W2588578960 @default.
• W2896109871 cites W2767226776 @default.
• W2896109871 cites W43225340 @default.
• W2896109871 cites W2111202886 @default.
• W2896109871 cites W2419095525 @default.
• W2896109871 doi "https://doi.org/10.1159/000493361" @default.
• W2896109871 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30304728" @default.
• W2896109871 hasPublicationYear "2018" @default.
• W2896109871 type Work @default.
• W2896109871 sameAs 2896109871 @default.
• W2896109871 citedByCount "20" @default.
• W2896109871 countsByYear W28961098712019 @default.
• W2896109871 countsByYear W28961098712020 @default.
• W2896109871 countsByYear W28961098712021 @default.
• W2896109871 countsByYear W28961098712022 @default.
• W2896109871 countsByYear W28961098712023 @default.
• W2896109871 crossrefType "journal-article" @default.
• W2896109871 hasAuthorship W2896109871A5033337879 @default.
• W2896109871 hasAuthorship W2896109871A5046855515 @default.
• W2896109871 hasAuthorship W2896109871A5059475139 @default.
• W2896109871 hasAuthorship W2896109871A5060735908 @default.
• W2896109871 hasAuthorship W2896109871A5068554505 @default.
• W2896109871 hasConcept C121608353 @default.
• W2896109871 hasConcept C126322002 @default.
• W2896109871 hasConcept C143998085 @default.
• W2896109871 hasConcept C197934379 @default.
• W2896109871 hasConcept C2776056115 @default.
• W2896109871 hasConcept C2776694085 @default.
• W2896109871 hasConcept C2777714996 @default.
• W2896109871 hasConcept C2778239845 @default.
• W2896109871 hasConcept C2778341716 @default.
• W2896109871 hasConcept C2778375690 @default.
• W2896109871 hasConcept C2780171596 @default.
• W2896109871 hasConcept C2780427987 @default.
• W2896109871 hasConcept C2781451048 @default.
• W2896109871 hasConcept C2992773878 @default.
• W2896109871 hasConcept C535046627 @default.
• W2896109871 hasConcept C71924100 @default.
• W2896109871 hasConceptScore W2896109871C121608353 @default.
• W2896109871 hasConceptScore W2896109871C126322002 @default.
• W2896109871 hasConceptScore W2896109871C143998085 @default.
• W2896109871 hasConceptScore W2896109871C197934379 @default.
• W2896109871 hasConceptScore W2896109871C2776056115 @default.
• W2896109871 hasConceptScore W2896109871C2776694085 @default.
• W2896109871 hasConceptScore W2896109871C2777714996 @default.
• W2896109871 hasConceptScore W2896109871C2778239845 @default.
• W2896109871 hasConceptScore W2896109871C2778341716 @default.
• W2896109871 hasConceptScore W2896109871C2778375690 @default.
• W2896109871 hasConceptScore W2896109871C2780171596 @default.
• W2896109871 hasConceptScore W2896109871C2780427987 @default.
• W2896109871 hasConceptScore W2896109871C2781451048 @default.
• W2896109871 hasConceptScore W2896109871C2992773878 @default.
• W2896109871 hasConceptScore W2896109871C535046627 @default.
• W2896109871 hasConceptScore W2896109871C71924100 @default.
• W2896109871 hasIssue "2" @default.

• next